Raymond A Cava, MD | |
11141 Parkview Plaza Dr Ste 305, Fort Wayne, IN 46845-1715 | |
(260) 484-9611 | |
(260) 484-1004 |
Full Name | Raymond A Cava |
---|---|
Gender | Male |
Speciality | General Surgery |
Experience | 32 Years |
Location | 11141 Parkview Plaza Dr Ste 305, Fort Wayne, Indiana |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1194726950 | NPI | - | NPPES |
200428480 | Medicaid | IN | |
104502717 | Medicaid | MI | |
2402975 | Medicaid | OH |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208600000X | Surgery | 01057472A (Indiana) | Secondary |
2086S0127X | Surgery - Trauma Surgery | 01057472A (Indiana) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Parkview Regional Medical Center | Fort wayne, IN | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Parkview Health System Inc | 2163336967 | 1167 |
News Archive
AB SCIEX, a global leader in life science analytical technologies, today announced the introduction of the AB SCIEX 4500 series, which is next-generation, mass spectrometry instrumentation that sets a new benchmark for routine quantitation and screening.
Boehringer Ingelheim today announced the initiation of a phase III clinical trial to investigate one of its most advanced oncology pipeline compounds, afatinib, for the treatment of patients with advanced (metastatic) breast cancer. Afatinib is an oral compound (taken as a tablet), which is a next generation, targeted therapy, that irreversibly inhibits both, the epidermal growth factor receptor (EGFR/HER1) and the human epidermal receptor HER2, which are involved in tumour growth and spread.
Inspire Pharmaceuticals, Inc. announced today financial results for the third quarter ended September 30, 2010, reporting a net loss of $7.6 million or ($0.09) per share, an improvement from the third quarter of 2009 during which the Company incurred a net loss of $8.5 million or ($0.12) per share.
The lack of a gene called LBP-1a in the mouse embryo prevents normal growth of blood vessels in the placenta. This finding suggests that a similar defect in humans could play a role in fetal growth retardation, infant mortality and spontaneous abortion.
› Verified 3 days ago
Entity Name | Parkview Health System Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1932130952 PECOS PAC ID: 2163336967 Enrollment ID: O20031117000288 |
News Archive
AB SCIEX, a global leader in life science analytical technologies, today announced the introduction of the AB SCIEX 4500 series, which is next-generation, mass spectrometry instrumentation that sets a new benchmark for routine quantitation and screening.
Boehringer Ingelheim today announced the initiation of a phase III clinical trial to investigate one of its most advanced oncology pipeline compounds, afatinib, for the treatment of patients with advanced (metastatic) breast cancer. Afatinib is an oral compound (taken as a tablet), which is a next generation, targeted therapy, that irreversibly inhibits both, the epidermal growth factor receptor (EGFR/HER1) and the human epidermal receptor HER2, which are involved in tumour growth and spread.
Inspire Pharmaceuticals, Inc. announced today financial results for the third quarter ended September 30, 2010, reporting a net loss of $7.6 million or ($0.09) per share, an improvement from the third quarter of 2009 during which the Company incurred a net loss of $8.5 million or ($0.12) per share.
The lack of a gene called LBP-1a in the mouse embryo prevents normal growth of blood vessels in the placenta. This finding suggests that a similar defect in humans could play a role in fetal growth retardation, infant mortality and spontaneous abortion.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Raymond A Cava, MD 11109 Parkview Plaza Dr # 117, Fort Wayne, IN 46845-1701 Ph: () - | Raymond A Cava, MD 11141 Parkview Plaza Dr Ste 305, Fort Wayne, IN 46845-1715 Ph: (260) 484-9611 |
News Archive
AB SCIEX, a global leader in life science analytical technologies, today announced the introduction of the AB SCIEX 4500 series, which is next-generation, mass spectrometry instrumentation that sets a new benchmark for routine quantitation and screening.
Boehringer Ingelheim today announced the initiation of a phase III clinical trial to investigate one of its most advanced oncology pipeline compounds, afatinib, for the treatment of patients with advanced (metastatic) breast cancer. Afatinib is an oral compound (taken as a tablet), which is a next generation, targeted therapy, that irreversibly inhibits both, the epidermal growth factor receptor (EGFR/HER1) and the human epidermal receptor HER2, which are involved in tumour growth and spread.
Inspire Pharmaceuticals, Inc. announced today financial results for the third quarter ended September 30, 2010, reporting a net loss of $7.6 million or ($0.09) per share, an improvement from the third quarter of 2009 during which the Company incurred a net loss of $8.5 million or ($0.12) per share.
The lack of a gene called LBP-1a in the mouse embryo prevents normal growth of blood vessels in the placenta. This finding suggests that a similar defect in humans could play a role in fetal growth retardation, infant mortality and spontaneous abortion.
› Verified 3 days ago
Dr. Ian H. Cook, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 2121 Lake Ave, Veterans Affairs Medical Center, Fort Wayne, IN 46805 Phone: 260-426-5431 | |
Brett J. Guinn, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2510 E Dupont Rd Ste 210, Fort Wayne, IN 46825 Phone: 260-458-3710 Fax: 260-458-3714 | |
Dr. Paul Mitchell Bauer, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: Lutheran Hospital, 7950 W Jefferson Blvd, Fort Wayne, IN 46804 Phone: 260-435-7001 | |
Lindsay B Hardley, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 11050 Parkview Circle Dr, Fort Wayne, IN 46845 Phone: 833-724-8326 Fax: 260-425-6845 | |
Dr. Keith David Clancy, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 7900 W Jefferson Blvd Ste 306, Fort Wayne, IN 46804 Phone: 260-458-3610 Fax: 260-458-3611 | |
Dr. Charles Michael Morgan, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 7950 W Jefferson Blvd, Fort Wayne, IN 46804 Phone: 260-432-2297 Fax: 260-434-6481 | |
Jeffery A Yoder, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 11141 Parkview Plaza Dr Ste 305, Fort Wayne, IN 46845 Phone: 260-484-9611 Fax: 260-484-1004 |